Clinical Trials for Lymphoma, T-Cell

Find clinical trials for lymphoma, t-cell. Discover research opportunities and treatment options in your area.

10 Active Trials Found

Showing 10 trials on this page

Page 1 of 1

A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant

NCT ID: NCT05540340

This clinical trial is studying a new method to calculate the dose of a chemotherapy drug called melphalan for patients with lymphoma who are preparing for a specific type of treatment known as an ...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

NCT ID: NCT04104776

This clinical trial is investigating a new treatment called CPI-0209 for patients with advanced solid tumors and lymphomas, including various types of cancer such as lymphoma and mesothelioma. CPI-...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, New York, New York, United States +92 more

MB-105 in Patients With CD5 Positive T-cell Lymphoma

NCT ID: NCT06534060

This clinical trial is studying a new treatment called MB-105 for patients with a specific type of T-cell lymphoma that has come back or hasn’t responded to previous treatments. The trial aims to f...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States, Boston, Massachusetts, United States +10 more

Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies

NCT ID: NCT06699771

This clinical trial is studying a new treatment called GCC2005 for patients with specific types of cancer known as T-cell and NK-cell malignancies. These are cancers that can be difficult to treat,...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of +3 more

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

NCT ID: NCT06561048

This clinical trial is studying a new treatment called soquelitinib for adults with specific types of relapsed or hard-to-treat peripheral T-cell lymphoma, including peripheral T-cell lymphoma not ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Burlingame, California, United States, South San Francisco, California, United States

A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

NCT ID: NCT05463263

This clinical trial is testing a new treatment called STP938 for adults with certain types of lymphoma, which is a cancer that affects the lymphatic system. The study has two parts: the first part ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Leicester, , United Kingdom, Denver, Colorado, United States +14 more

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/refractory Indolent T/NK-cell Lymphomas

NCT ID: NCT06716658

This clinical trial is studying a new treatment called Golidocitnib for patients with indolent T/NK-cell lymphomas, which are types of blood cancers that grow slowly but are currently hard to cure....

Recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, , China, Tianjin, Tianjin, China

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

NCT ID: NCT05476770

This clinical trial is studying a new treatment called tagraxofusp for children and young adults with certain types of blood cancers that have not responded to previous treatments. Tagraxofusp work...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, New York, New York, United States +29 more

PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

NCT ID: NCT06530550

This clinical trial is studying the use of new medications called PI3K inhibitors to treat patients with indolent T/NK-cell lymphomas that have not responded to earlier treatments. These types of l...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, Tianjin, China

ChiCGB vs BEAM in High-risk or R/R Lymphomas

NCT ID: NCT05466318

This clinical trial is comparing two treatment methods for patients with high-risk or relapsed lymphoma, specifically looking at a new combination therapy called ChiCGB, which includes chidamide, c...

Recruiting

Phase: PHASE3 Type: interventional Locations: Nanchong, Sichuan, China, Chendu, Sichuan, China +9 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions